Want to join the conversation?
$AVAV's 1Q17 GM fell to $6.7MM or 18%, mainly due to a decline in product margin. Product GM percentage was 3.3% and service margin was consistent at 30.1%. SG&A expense was $13.7MM or 38% of revenue and R&D expense was $8.6MM or 24% of revenue in the quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?